The European Union consists of 500 million doses of Pfizer and Modern vehicles

La European Commission announces this Wednesday the buy from 500 million additional doses of vaccines against coronavirus, with the acquisition of more vials from BioNTech / Pfizer and Moderna.

First reading the confirmation of the new agreement with the German company and its stadium society, which is agreed with the European Commission on the sale of 200 million additional doses and the option to purchase another 100 million. These amount to the 300 million doses that the EU has required in advance in these laboratories.

Posteriormente, the President of the European Commission, Ursula von der Leyen, announced the purchase of 300 million additional dose of Moderna, in addition to the 160 million that it has contracted with the pharmaceutical industry. Detailed, son 150 million for this year and the option of another 150 million for 2021.

Von der Leyen communicates to present the new strategy of the European Union to stimulate the investigation, production and authorization of vehicles against the new variants of coronavirus. “We are approaching our objective of ensuring that all Europeans have access to safe and efficient vehicles as quickly as possible,” he said.

With these companies, the UE totals 960 million in single dose between Pfizer and Modern, compared to the millions of doses sold at the University of Oxford / AstraZeneca and the possible contract with the Gamaleya Institute for the Sputnik vaccine. Taking into account that the vaccination regimen of these formulas consists of doses, its sufficient for vaccination to the 450 million inhabitants, a figure that is reduced and that the vaccinations are not authorized for minor editions.

In sum, the EU has secured 2,600 million COVID-19 vacancies for the six vacancy manufacturers, according to the Commission, sufficient to evacuate three weeks to all of its population, although it is possible that all the forms are superen with the success of the clinical trials.

Following the contract with Pfizer, the 200 million additional doses will also be deducted for the length of this year and part of them, 75 million during the second quarter. “We are aware that more people are being vaccinated to eradicate the virus in Europe and contain the pandemic worldwide. We are working tirelessly to support Europe’s vacancy campaigns and to increase our production capacity worldwide, ”said Albert Bourla, CEO of Pfizer.

The CEO of BioNTech, Ugur Sahin, for his part, said that the large access to efficient vacancies is key to prevent a pandemic by which the company will increase its production capacity to produce 2,000 million doses by 2021. Sahin recorded that the new factory in Marburg (Germany’s center) was trying to produce this machine and that BioNTech had extended its network of cooperatives.

An Escala everyday, the “high” and “high media” interest rates (according to the World Bank) concentrate more on each dose dose (93%), only that albergan has a share (53%) of the world population.

(With EFE information)

MORE ABOUT THIS THEME:

Oscar Cingolani, Scientific of the Johns Hopkins University: “A desiccated distribution of vacancies is dangerous for humanity”

The United Kingdom has authorized coronavirus to infect humans to test the efficacy of pharmacies and vaccines